Effective Dosing of Burosumab in XLH — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effective Dosing of Burosumab in XLH — Stella

Recruiting

Back to X-linked Hypophosphatemia (XLH) trials

Trial locations(1 site)

United Kingdom

Nottingham University Hospitals NHS Trust, Nottingham

Key details

Sponsor

University of Nottingham

Collaborators

Nottingham University Hospitals NHS Trust, Birmingham Women's and Children's NHS Foundation Trust

Enrollment target

~120 participants

Started

September 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

2 Years – 18 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov